SeekGene

About SeekGene

SeekGene operates in the biotechnology sector, specializing in single cell RNA sequencing and TCR pMHC pairing technologies. The company serves researchers and healthcare professionals who require detailed insights into immune responses at the single cell level. SeekGene's core products include the SeekOne Single Cell Sequencing Platform and the SeekPair TCR pMHC Pairing Platform. The SeekOne platform utilizes advanced microfluidics, bioenzymatics, and informatics to provide high throughput single cell transcriptome analysis, capable of processing 10,000 cells efficiently and economically. The SeekPair platform offers comprehensive information on paired TRA and TRB sequences from single T cells, including their status and MHC restricted antigens. SeekGene's business model revolves around selling these proprietary platforms and related services to research institutions, pharmaceutical companies, and clinical labs. Revenue is generated through the sale of equipment, consumables, and data analysis services. The company operates in a niche market focused on immunology and personalized medicine, aiming to enhance disease screening, treatment, and monitoring.